Phospho-TAL1 (S122) Antibody

What is TAL1 and why is phosphorylation at Serine 122 significant in research contexts?

TAL1 (T-cell acute lymphocytic leukemia protein 1) is a basic helix-loop-helix (bHLH) transcription factor that plays critical roles in hematopoietic differentiation and development. It exists in two main forms: a full-length protein (pp42TAL1, residues 1-331) and a truncated version (pp22TAL1, residues 176-331) .

Phosphorylation at Serine 122 (S122) is particularly significant because:

• It represents a major regulatory mechanism for modulating TAL1 activity in response to extracellular signals

• S122 phosphorylation is induced by epidermal growth factor with timing that parallels the activation of ERK/MAP2 protein kinases

• This post-translational modification is strongly stimulated by hypoxia and can subsequently trigger ubiquitination, targeting the protein for rapid degradation

• Phosphorylation at S122 alters DNA binding activity in a target-dependent manner, influencing both the specific CANNTG E-box core motif and its flanking sequences

Understanding this phosphorylation event is crucial for researchers investigating hematopoietic malignancies, as TAL1 alteration is the most common genetic lesion found in T-cell acute lymphoblastic leukemia .

For proper experimental validation, researchers should consider the following positive control strategies:

• Jurkat cells treated with PMA (125ng/ml for 30 minutes) serve as an effective positive control for Western blot applications

• JK cells are recommended as a positive control by multiple antibody suppliers

• For enhanced phosphorylation signal, treatment with epidermal growth factor can be employed, as it rapidly induces S122 phosphorylation

• When validating antibody specificity, using phospho-peptide blocking controls (peptides containing phosphorylated S122) can confirm the phospho-specificity of the antibody

A systematic validation approach should include both positive controls (cells known to express phospho-TAL1) and negative controls (phospho-peptide blocked samples or TAL1 knockout cells) .

How does phosphorylation at S122 mechanistically affect TAL1 function in hematopoietic development and leukemogenesis?

The phosphorylation of TAL1 at S122 has several mechanistic consequences that impact both normal hematopoiesis and leukemic transformation:

• DNA Binding Modulation: Phosphorylation alters TAL1 DNA binding activity in a target-dependent manner. Research has demonstrated that this modification influences binding affinity to specific E-box motifs (CANNTG) and is affected by both the core motif and flanking sequences .

• Protein Stability Regulation: In microvascular endothelial cells, hypoxia-dependent phosphorylation of S122 triggers ubiquitination and subsequent degradation via the ubiquitin system . This represents a tissue-specific regulatory mechanism, as this process is not observed in large vessel endothelial cells.

• Signal Integration Pathway: S122 serves as an in vivo substrate for ERK/MAP2 kinases, particularly ERK1 . This provides a mechanistic link between extracellular stimuli (such as growth factors) and TAL1 activity, allowing cells to modulate transcriptional programs in response to environmental cues.

• Transcriptional Complex Formation: While phosphorylation at S122 affects DNA binding, research indicates it does not impair TAL1's ability to interact with the E2A gene product E12 or alter its subcellular localization . This suggests that phosphorylation primarily regulates target gene selection rather than protein-protein interactions within transcriptional complexes.

Understanding these mechanistic details is crucial for researchers investigating TAL1's role in normal development versus its oncogenic functions in T-ALL.

What methodological considerations should be addressed when comparing different Phospho-TAL1 (S122) antibodies for research?

When selecting and comparing different Phospho-TAL1 (S122) antibodies for research, consider the following methodological aspects:

• Epitope Region Specificity:

  • Verify the exact epitope region recognized by the antibody. High-quality phospho-TAL1 (S122) antibodies are typically generated against synthetic peptides spanning the region around S122 (approximately amino acids 96-145) .

  • Antibodies targeting different epitope regions surrounding the phosphorylation site may exhibit varying specificities and sensitivities.

• Antibody Format and Species Compatibility:

  • Both monoclonal and polyclonal antibodies are available (e.g., monoclonal from mouse or polyclonal from rabbit ).

  • Cross-reactivity between species should be evaluated - most antibodies react with both human and mouse TAL1 , but reactivity with other species may vary.

• Validation Controls:

  • Employ both positive controls (PMA-stimulated Jurkat cells ) and negative controls (phospho-peptide competitive inhibition or ideally TAL1 knockout samples).

  • Consider the impact of neighboring post-translational modifications on antibody recognition, as observed with other phospho-specific antibodies .

• Application-Specific Optimization:

  • Dilution requirements vary significantly between applications (1:500-1:2000 for WB vs. 1:10000 for ELISA) .

  • Buffer composition may affect antibody performance (most are supplied in PBS with 50% glycerol, 0.5% BSA and 0.02% sodium azide) .

• Batch-to-Batch Consistency:

  • Request validation data from vendors showing consistent performance across production batches.

  • Consider performing in-house validation when switching antibody batches or suppliers.

Western Blot Protocol Optimization:

• Sample Preparation:

  • Cells should be lysed in buffer containing phosphatase inhibitors to preserve phosphorylation status

  • For enhanced phospho-TAL1 signal, stimulate cells with PMA (125ng/ml, 30 minutes) or epidermal growth factor prior to lysis

• Gel Electrophoresis Parameters:

  • Expect to visualize a band at approximately 45kDa for full-length phospho-TAL1

  • Use 8-12% SDS-PAGE gels for optimal resolution

• Transfer and Blocking:

  • PVDF membranes are recommended for phospho-protein detection

  • Block using 5% BSA in TBST rather than milk, as milk contains phospho-proteins that may interfere with detection

• Antibody Incubation:

  • Primary antibody dilution: 1:500-1:2000

  • Incubate overnight at 4°C for optimal signal-to-noise ratio

  • Include phospho-peptide blocked controls to confirm specificity

Immunohistochemistry Protocol:

• Antigen Retrieval:

  • Use Tris-EDTA buffer (pH 9.0) for optimal antigen retrieval

  • Heat-induced epitope retrieval is recommended

• Antibody Application:

  • Dilute antibody 1:100-1:300

  • Incubate at 4°C overnight

  • Secondary antibody should be applied at 1:200 dilution (room temperature, 45 minutes)

• Sample Types:

  • Validated on paraffin-embedded human tonsil sections

  • Particularly effective for detecting phospho-TAL1 in leukemic stem cells

Immunofluorescence Protocol:

• Cell Preparation:

  • Fix cells in 4% paraformaldehyde

  • Permeabilize with 0.1% Triton X-100

• Antibody Application:

  • Use 1:50-1:200 dilution range

  • Counterstain with DAPI to visualize nuclei

  • Expect nuclear localization signal for phospho-TAL1

Each protocol should be optimized based on specific experimental conditions and sample types.

What are common challenges in phospho-TAL1 (S122) detection and how can they be overcome?

Researchers frequently encounter several challenges when working with phospho-TAL1 (S122) antibodies:

• Phosphorylation Instability:

  • Challenge: Rapid dephosphorylation during sample preparation

  • Solution: Add phosphatase inhibitor cocktails to all buffers; process samples quickly; maintain cold temperatures throughout preparation

• Background and Non-specific Binding:

  • Challenge: High background, particularly in Western blots

  • Solution: Block with 5% BSA instead of milk; optimize antibody dilution (start with 1:1000 for WB ); include phospho-peptide blocking controls

• Sensitivity Issues:

  • Challenge: Low signal due to minimal phosphorylation levels

  • Solution: Stimulate cells with PMA (125ng/ml, 30 minutes) or epidermal growth factor to enhance S122 phosphorylation ; use enhanced chemiluminescence detection systems; consider signal amplification methods

• Cross-reactivity with Neighboring Modifications:

  • Challenge: Interference from other post-translational modifications near S122

  • Solution: Similar to issues observed with other phospho-specific antibodies , carefully validate antibody specificity using peptide competition assays with phosphorylated and non-phosphorylated peptides

• Inconsistent Results Across Applications:

  • Challenge: Antibody performs well in one application (e.g., WB) but not in others (e.g., IF)

  • Solution: Adjust dilution substantially between applications (1:500-1:2000 for WB vs. 1:10000 for ELISA) ; optimize fixation and antigen retrieval methods for each application

How does the co-occurrence of multiple post-translational modifications affect phospho-TAL1 (S122) antibody specificity?

This question addresses an important advanced consideration in phospho-antibody research. While specific data for phospho-TAL1 (S122) antibodies is limited, insights can be drawn from research on other phospho-specific antibodies :

• Impact of Neighboring Modifications:

  • Co-occurrence of post-translational modifications (PTMs) near S122 may influence antibody recognition

  • TAL1 is known to be phosphorylated at multiple serine residues, including S172 , which could potentially affect S122 antibody binding

• Potential Modification Interactions:

  • After S122 phosphorylation under hypoxic conditions, TAL1 undergoes ubiquitination

  • The presence of ubiquitin chains may sterically hinder antibody access to the phospho-S122 epitope

• Methodological Approaches to Address This Issue:

  • Validate antibody specificity using synthetic peptides with various modification patterns

  • Include controls with inducible phosphorylation (e.g., PMA treatment) and dephosphorylation (e.g., phosphatase treatment)

  • When possible, use complementary detection methods (mass spectrometry) to confirm phosphorylation status

• Antibody Selection Criteria:

  • Choose antibodies validated against multiple modification states

  • Request modification-specific validation data from suppliers

  • Consider using multiple antibodies targeting different epitopes surrounding the phospho-S122 site

What is the relationship between TAL1 S122 phosphorylation and its role in T-cell acute lymphoblastic leukemia progression?

Understanding the functional significance of S122 phosphorylation in leukemogenesis is critical for researchers using phospho-TAL1 antibodies in cancer studies:

• Signaling Pathway Integration:

  • S122 phosphorylation connects TAL1 activity to the ERK/MAPK signaling pathway

  • This provides a mechanism by which extracellular growth factors and mitogenic signals can modulate TAL1 transcriptional programs in leukemic cells

• Target Gene Regulation:

  • Phosphorylation at S122 alters DNA binding activity in a target-dependent manner

  • This selective modification of binding affinity may redirect TAL1 to oncogenic target genes in T-ALL

• Leukemic Stem Cell Biology:

  • Phospho-TAL1 (S122) is expressed in leukemic stem cells

  • Monitoring phosphorylation status may provide insights into leukemic stem cell biology and therapy resistance

• TAL1 Activation Mechanisms:

  • TAL1 can be activated through various mechanisms in T-ALL, including chromosomal translocations, SIL-TAL1 microdeletions, and non-coding mutations

  • The phosphorylation status of S122 may differ between these different activation contexts

• Therapeutic Implications:

  • Targeting the kinases responsible for S122 phosphorylation (e.g., ERK1) could potentially modulate TAL1 activity

  • Phospho-TAL1 (S122) antibodies serve as valuable tools for monitoring response to such targeted therapies

Researchers investigating these relationships should employ phospho-TAL1 (S122) antibodies alongside other molecular tools to comprehensively characterize TAL1's role in leukemogenesis.

How can phospho-TAL1 (S122) antibodies be used in multi-parameter flow cytometry for leukemia research?

Flow cytometry applications with phospho-TAL1 (S122) antibodies represent an advanced research direction:

• Protocol Development Considerations:

  • Cell fixation and permeabilization are critical - use paraformaldehyde fixation followed by methanol or saponin permeabilization

  • Signal amplification may be necessary due to relatively low abundance of phospho-proteins

  • Begin with antibody dilutions of 1:50-1:100, which is in the lower range of IF dilutions

• Multi-parameter Panel Design:

  • Combine with surface markers (CD34, CD7, CD3) for identifying specific T-cell populations

  • Include other intracellular markers (NOTCH1, LMO2) relevant to T-ALL biology

  • Consider using fluorochromes with minimal spectral overlap for phospho-TAL1 detection

• Control Strategies:

  • Use isotype controls matched to the phospho-TAL1 antibody class (IgG)

  • Include both positive controls (PMA-stimulated cells) and negative controls (phosphatase-treated cells)

  • Consider using TAL1-negative cell lines as biological negative controls

• Data Analysis Approaches:

  • Gate on viable singlet cells before analyzing phospho-TAL1 signal

  • Compare median fluorescence intensity rather than percent positive cells

  • Consider dimensional reduction techniques (tSNE, UMAP) for identifying phospho-TAL1+ subpopulations

What are the emerging applications of phospho-TAL1 (S122) antibodies in single-cell analysis techniques?

Phospho-TAL1 (S122) antibodies are increasingly being adapted for cutting-edge single-cell analysis techniques:

• Single-Cell Western Blotting:

  • Miniaturized Western blot systems allow protein analysis at the single-cell level

  • Use phospho-TAL1 antibodies at the higher end of the concentration range (1:500)

  • This approach can reveal cell-to-cell heterogeneity in phosphorylation status within tumor samples

• Mass Cytometry (CyTOF):

  • Metal-conjugated phospho-TAL1 antibodies enable highly multiplexed analysis

  • Combine with other transcription factors and signaling molecules for comprehensive single-cell profiling

  • Requires thorough validation of metal-conjugated antibodies against conventional fluorochrome-labeled versions

• Imaging Mass Cytometry:

  • Combines mass cytometry with tissue imaging capabilities

  • Allows visualization of phospho-TAL1 in spatial context within tissue microenvironment

  • Particularly valuable for studying TAL1 activation in leukemic infiltrates

• Single-Cell Sequencing Integration:

  • CITE-seq approaches can combine phospho-protein detection with transcriptomics

  • Correlate phospho-TAL1 levels with gene expression signatures at single-cell resolution

  • This integrated approach can reveal how phosphorylation status influences transcriptional programs

These emerging applications require rigorous validation of antibody specificity and careful optimization of protocols for single-cell contexts.

How can computational approaches enhance the interpretation of phospho-TAL1 (S122) experimental data?

Modern computational methods can significantly enhance the value of phospho-TAL1 (S122) antibody-generated data:

• Network Analysis:

  • Integrate phospho-TAL1 data with protein-protein interaction networks

  • TAL1 interacts with several proteins including TCF3, LMO2, LDB1, and CBFA2T3 in a complex

  • Computational models can predict how S122 phosphorylation may influence these interactions

• Phosphorylation Site Conservation Analysis:

  • Compare S122 and surrounding sequences across species

  • Evaluate evolutionary conservation as an indicator of functional importance

  • Identify species where phospho-TAL1 (S122) antibodies may cross-react based on sequence homology

• Structural Biology Integration:

  • Use molecular dynamics simulations to model the effect of S122 phosphorylation on TAL1 protein structure

  • Predict how structural changes might influence DNA binding to E-box motifs

  • Generate testable hypotheses about phosphorylation-induced conformational changes

• Multi-omics Data Integration:

  • Correlate phospho-TAL1 levels with transcriptomic, epigenomic, and proteomic datasets

  • Identify gene expression signatures specifically associated with S122 phosphorylation status

  • Develop predictive models for TAL1 phosphorylation based on upstream signaling pathway activation

These computational approaches transform phospho-TAL1 antibody data from descriptive observations into mechanistic insights and predictive models.